Vendor Watch

Pink Pony Peptides

UNKNOWN

Last checked

Not checked. Listed because of an FDA warning letter; we did not review the company’s site.

Latest item

Apr. 7, 2026: FDA posted a warning letter dated Mar. 31, 2026 (Wellington, FL) citing unapproved new drug violations.

Public enforcement record

FDA warning letter dated Mar. 31, 2026, posted Apr. 7, 2026, citing sections 301(d) and 505(a) of the FD&C Act. These are FDA’s allegations; the firm was given 15 working days to respond.

Company response

None located. We did not search beyond the FDA page.

Timeline

2026-03-31FDA issues a warning letter to the firm (Wellington, FL).
2026-04-07FDA posts the letter.

Current storefront and channel observations

No observations recorded.

Documented enforcement records

Product additions and removals

No product changes recorded.

Statements and replies

No statements located.

Stories

FDA FILEDOCUMENTED
FDA sends warning letters to five peptide sellers that also offered bacteriostatic water

DOCUMENTED. FDA posted warning letters on Apr. 7, 2026 (dated Mar. 31) to five peptide sellers, citing unapproved new drug violations; all five letters also name bacteriostatic water sold alongside the peptides. The letters are FDA’s allegations; each firm had 15 working days to respond.

Observed 2026-04-07 · Published 2026-10-05

Community chatter

Kept separate from confirmed reporting. Not verified.

None recorded.

Updates and corrections

None. Request a correction.

Record note: This page is a dated record of public documents, observed website changes, company statements, and clearly labeled community discussion. It is updated as new information becomes available.